Skip to main content
Tilray Brands, Inc. logo

Tilray Brands, Inc. — Investor Relations & Filings

Ticker · TLRY ISIN · US88688T2096 LEI · 549300Y4V60733TO1478 TSX Manufacturing
Filings indexed 397 across all filing types
Latest filing 2026-04-16 Regulatory Filings
Country US United States of America
Listing TSX TLRY

About Tilray Brands, Inc.

https://www.tilray.com/

Tilray Brands, Inc. is a global consumer packaged goods and cannabis-lifestyle company focused on enhancing wellbeing through innovative products. The company operates a diversified portfolio encompassing pharmaceutical, medical, and recreational cannabis, alongside consumer packaged goods, including beverages. Tilray is a leading producer of GMP-certified medical cannabis and holds the top market share position in the Canadian recreational cannabis sector. Leveraging advanced greenhouse cultivation and an extensive global supply chain, Tilray distributes a wide range of products—such as whole flower, vapes, and pre-rolls—across key markets in Canada, Europe, the United States, Australia, and Latin America.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2026-04-16 English
Other.pdf
Regulatory Filings
2026-04-01 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Sarbanes-Oxley Section 302 certification signed by the CEO. According to the 'CERTIFICATION RULE' provided in the instructions, documents that are primarily officer certifications or attestations—even if they reference a specific report like a 10-Q—must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2026
2026-04-01 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Sarbanes-Oxley Section 302 certification signed by the CFO. According to the 'CERTIFICATION RULE' provided in the instructions, documents that are primarily officer certifications or attestations, even if they reference a specific report like a 10-Q, must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2026
2026-04-01 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Sarbanes-Oxley Section 302 certification signed by the CEO. According to the 'CERTIFICATION RULE' provided in the instructions, documents that are primarily officer certifications or attestations—even if they reference a specific report like a 10-Q—must be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive financial data. Q3 2026
2026-04-01 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Sarbanes-Oxley Section 302 certification signed by the CFO. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report like a 10-Q, should be classified as Regulatory Filings (RNS) rather than the report itself, as they do not contain the actual financial statements or substantive data. Q3 2026
2026-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.